|
Basic Characteristics of Mutations
|
|
Mutation Site
|
G29S |
|
Mutation Site Sentence
|
The natural mutation of glycine 29 to serine (Fig. 1A) resulted in the G29S mutant that produces mainly p12. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
p12 |
|
Standardized Encoding Gene
|
pX
|
|
Genotype/Subtype
|
- |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Cell line
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
- |
|
Location
|
- |
|
Literature Information
|
|
PMID
|
24284316
|
|
Title
|
Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission
|
|
Author
|
Edwards D,Fukumoto R,de Castro-Amarante MF,Alcantara LC,Galvao-Castro B,Washington Parks R,Pise-Masison C,Franchini G
|
|
Journal
|
Journal of virology
|
|
Journal Info
|
2014 Feb;88(4):2319-22
|
|
Abstract
|
The orf-I gene of human T-cell leukemia type 1 (HTLV-1) encodes p8 and p12 and has a conserved cysteine at position 39. p8 and p12 form disulfide-linked dimers, and only the monomeric forms of p8 and p12 are palmitoylated. Mutation of cysteine 39 to alanine (C39A) abrogated dimerization and palmitoylation of both proteins. However, the ability of p8 to localize to the cell surface and to increase cell adhesion and viral transmission was not affected by the C39A mutation.
|
|
Sequence Data
|
-
|